172 related articles for article (PubMed ID: 15467916)
1. Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2.
Schneider B; Becker M; Brackmann HH; Eis-Hübinger AM
Thromb Haemost; 2004 Oct; 92(4):838-45. PubMed ID: 15467916
[TBL] [Abstract][Full Text] [Related]
2. Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4.
Schneider B; Fryer JF; Oldenburg J; Brackmann HH; Baylis SA; Eis-Hübinger AM
Haemophilia; 2008 Sep; 14(5):978-86. PubMed ID: 18565125
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates.
Modrow S; Wenzel JJ; Schimanski S; Schwarzbeck J; Rothe U; Oldenburg J; Jilg W; Eis-Hübinger AM
Vox Sang; 2011 May; 100(4):351-8. PubMed ID: 21133933
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing.
Geng Y; Wu CG; Bhattacharyya SP; Tan D; Guo ZP; Yu MY
Transfusion; 2007 May; 47(5):883-9. PubMed ID: 17465954
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19 transmission by heat-treated clotting factor concentrates.
Blümel J; Schmidt I; Effenberger W; Seitz H; Willkommen H; Brackmann HH; Löwer J; Eis-Hübinger AM
Transfusion; 2002 Nov; 42(11):1473-81. PubMed ID: 12421221
[TBL] [Abstract][Full Text] [Related]
6. Parvovirus transmission by blood products - a cause for concern?
Norja P; Lassila R; Makris M
Br J Haematol; 2012 Nov; 159(4):385-93. PubMed ID: 23025427
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
Baylis SA; Shah N; Minor PD
J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
[TBL] [Abstract][Full Text] [Related]
8. Human parvovirus PARV4 in clotting factor VIII concentrates.
Fryer JF; Hubbard AR; Baylis SA
Vox Sang; 2007 Nov; 93(4):341-7. PubMed ID: 18070279
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 transmission by a high-purity factor VIII concentrate.
Wu CG; Mason B; Jong J; Erdman D; McKernan L; Oakley M; Soucie M; Evatt B; Yu MY
Transfusion; 2005 Jun; 45(6):1003-10. PubMed ID: 15935000
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction.
Zakrzewska K; Azzi A; Patou G; Morfini M; Rafanelli D; Pattison JR
Br J Haematol; 1992 Jul; 81(3):407-12. PubMed ID: 1390215
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus B19 DNA in plasma pools and plasma derivatives.
Schmidt I; Blümel J; Seitz H; Willkommen H; Löwer J
Vox Sang; 2001 Nov; 81(4):228-35. PubMed ID: 11903998
[TBL] [Abstract][Full Text] [Related]
12. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
13. Analysis of B19 virus contamination in plasma pools for manufacturing, by using a competitive polymerase chain reaction assay.
Gallinella G; Moretti E; Nardi G; Zuffi E; Bonvicini F; Bucci E; Musiani M; Zerbini M
Vox Sang; 2002 Nov; 83(4):324-31. PubMed ID: 12437519
[TBL] [Abstract][Full Text] [Related]
14. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus.
Bonvicini F; Gallinella G; Cricca M; Ambretti S; Delbarba S; Musiani M; Zerbini M
J Med Virol; 2004 Oct; 74(2):272-6. PubMed ID: 15332276
[TBL] [Abstract][Full Text] [Related]
15. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies.
Prikhod'ko GG; Vasilyeva I; Reyes H; Wong S; Brown KE; Jameson T; Busby TF
Transfusion; 2005 Jun; 45(6):1011-9. PubMed ID: 15935001
[TBL] [Abstract][Full Text] [Related]
17. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.
Santagostino E; Mannucci PM; Gringeri A; Azzi A; Morfini M; Musso R; Santoro R; Schiavoni M
Transfusion; 1997 May; 37(5):517-22. PubMed ID: 9149778
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.
Soucie JM; De Staercke C; Monahan PE; Recht M; Chitlur MB; Gruppo R; Hooper WC; Kessler C; Kulkarni R; Manco-Johnson MJ; Powell J; Pyle M; Riske B; Sabio H; Trimble S;
Transfusion; 2013 Jun; 53(6):1217-25. PubMed ID: 22998193
[TBL] [Abstract][Full Text] [Related]
19. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests.
Hokynar K; Norja P; Laitinen H; Palomäki P; Garbarg-Chenon A; Ranki A; Hedman K; Söderlund-Venermo M
J Clin Microbiol; 2004 May; 42(5):2013-9. PubMed ID: 15131163
[TBL] [Abstract][Full Text] [Related]
20. Maternal-fetal transmission of human parvovirus B19 genotype 3.
Candotti D; Danso K; Parsyan A; Dompreh A; Allain JP
J Infect Dis; 2006 Sep; 194(5):608-11. PubMed ID: 16897659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]